The Department of Ophthalmology supports innovative basic science and clinical research aimed towards developing therapies for ocular diseases and conditions.

Joined May 2019
6 Photos and videos
Pitt Ophthalmology Research retweeted
Rob Lin, PhD, CEO, Avista Therapeutics, says scAAVenger platform provides a cell-specific toolkit for gene therapy development, resulting in higher expression and lower inflammation with lower gene therapy doses. Avista management includes Sahel, Sieving, Byrne.
2
4
Pitt Ophthalmology Research retweeted
Si Chen, Kira Lathrop, Takaaki Kuwajima and Jeffrey Gross dissect the role of Jak/Stat signalling in modulating crosstalk between macrophages/microglia and retinal ganglion cells to regulate RGC survival after severe optic nerve injury journals.biologists.com/dev/…
1
1
Exciting news for Ophthalmology! pittwire.pitt.edu/news/fda-a…

2
New!! The St. Leger Lab shows that VEGF-A immune cells disrupts corneal nerves leading to blinding disease during HSV-1 infection. @Immunity Check it out:authors.elsevier.com/a/1c5K5…

2
Postdoctoral Fellow in the epigenetic regulation of retinal development NIH-funded postdoctoral position is available in the laboratory of Dr. Jeff Gross (jeffgrosslab.org) in the Department of Ophthalmology at Pitt Interested candidates send info to grossjm@pitt.edu

Great opportunity in Pittsburgh!
1
A new Review article by Jeff Gross on eye evolution: Evolution and development of complex eyes: a celebration of diversity dev.biologists.org/content/1…

1
Check out the @PittMedMag article featuring our very own Ian Sigal! pittmed.health.pitt.edu/stor…

2
Happy 60th Anniversary to @RPB_org and their President, Dr. Brian Hofland Consider making an anniversary donation to the RPB via the attached link: rpbusa.org/rpb/support/donat…

1
1
Incredibly proud of the Funderburgh Lab
The Funderburgh Lab published in Stem Cells Translational Medicine today! Get your read on! rdcu.be/bJEqY
1
1
Simply Amazing!
13 Jan 2020
UPMC physicians first to implant next regeneration wireless retinal device in clinical trial to restore partial sight to patients with advanced age-related macular degeneration, which leads to permanent blindness and has no cure. upmc.me/3a71iCz